dr. R. (Rik) Rozemeijer

dr. R. (Rik) Rozemeijer

Research Staff Other
  • Radiology

Research Output (15)

Patient-tailored antithrombotic therapy following percutaneous coronary intervention

van der Sangen Niels M R, Rozemeijer Rik, Chan Pin Yin Dean R P P, Valgimigli Marco, Windecker Stephan, James Stefan K, Buccheri Sergio, Ten Berg Jurriën M, Henriques José P S, Voskuil Michiel, Kikkert Wouter J 29 jan 2021, In: European heart journal. 42 , p. 1038-1046 9 p.

Advances in percutaneous coronary intervention and antiplatelet therapy in ischemic heart disease

Rozemeijer Rik 10 sep 2019, 170 p.

Incidence, angiographic and clinical predictors, and impact of stent thrombosis:a 6-year survey of 6,545 consecutive patients

Rozemeijer R., Wong C. Wing, Leenders G., Timmers L., Koudstaal S., Rittersma S. Z., Kraaijeveld A., Bots M., Doevendans P., Stella P., Voskuil M. 20 mrt 2019, In: Netherlands Heart Journal. 27 , p. 321-329

Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent

Rozemeijer Rik, Stein Mera, Voskuil Michiel, van den Bor Rutger, Frambach Peter, Pereira Bruno, Koudstaal Stefan, Leenders Geert E, Timmers Leo, Rittersma Saskia Z, Kraaijeveld Adriaan O, Agostoni Pierfrancesco, Roes Kit C, Doevendans Pieter A, Stella Pieter R, 2 jan 2019, In: Circulation. 139 , p. 67-77 11 p.

One-year clinical outcomes of patients treated with polymer-free amphilimus-eluting stents or zotarolimus-eluting stents:A propensity-score adjusted analysis

Rozemeijer Rik, van Muiden Ivar G, Koudstaal Stefan, Leenders Geert E, Timmers Leo, Rittersma Saskia Z, Kraaijeveld Adriaan O, Doevendans Pieter A, Voskuil Michiel, Stella Pieter R 2 jan 2019, In: Catheterization and Cardiovascular Interventions. 94 , p. 61-69 9 p.

Duration of dual antiplatelet therapy after percutaneous coronary intervention:Is less more?

Rozemeijer Rik, Van Bezouwen Wijnand P., Voskuil Michiel, Stella Pieter R. 1 dec 2018, In: US Cardiology Review. 12 , p. 91-97 7 p.

Clinical outcomes of complex real-world diabetic patients treated with amphilimus sirolimus-eluting stents or zotarolimus-eluting stents:A single-center registry

Rozemeijer Rik, Benedetto Daniela, Kraaijeveld Adriaan O., Voskuil Michiel, Stein Mèra, Timmers Leo, Rittersma Saskia Z., Agostoni Pierfrancesco, Doevendans Pieter A., Stella Pieter R. jul 2018, In: Cardiovascular revascularization medicine : including molecular interventions. 19 , p. 521-525

Short versus long duration of dual antiplatelet therapy following drug-eluting stents:a meta-analysis of randomised trials

Rozemeijer R, Voskuil M, Greving J P, Bots M L, Doevendans P A, Stella P R mei 2018, In: Netherlands Heart Journal. 26 , p. 242-251

Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial:A multicenter randomized clinical trial

Rozemeijer Rik, Stein Mèra, Frambach Peter, Voskuil Michiel, Kraaijeveld Adriaan O, Rodríguez-Olivares Ramón, Timmers Leo, Pereira Bruno, Rittersma Saskia, Agostoni Pierfrancesco, Doevendans Pieter A, Stella Pieter R 15 feb 2018, In: Catheterization and Cardiovascular Interventions. 91 , p. 410-416

Short versus long DAPT following PCI, a systematic review and meta-analysis

Rozemeijer Rik, Voskuil Michiel, Stella Pieter 31 okt 2017, In: Journal of the American College of Cardiology. 70 , p. B226-B227 2 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet